Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 3 pseudogene 2 (SLC25A3P2)
- Target
- SLC25A3P2
- Molecular classification
- Pseudogene (processed), Noncoding RNA (potential if transcribed)
01
Overview
Solute carrier family 25 member 3 pseudogene 2 (SLC25A3P2) is a processed pseudogene located in the human genome. It is related by sequence to the SLC25A3 gene, which encodes a mitochondrial phosphate carrier involved in ATP synthesis, but SLC25A3P2 itself is noncoding and does not produce a functional protein. Like other pseudogenes, it is considered by genomic annotation resources to be non-functional at the protein level, though some pseudogenes can influence gene regulation in certain contexts. There are no known established biological, pathological, or pharmacological roles for this specific pseudogene.SLC25A3P2 is not to be confused with SLC25A3, which is a functional mitochondrial phosphate transporter and a true member of the solute carrier family. By all current genomic annotations, SLC25A3P2 lacks coding potential and is generally not considered a therapeutic target, biomarker, or molecular pathway node.
- Other names
- SLC25A3P2solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 pseudogene 2
02
Biological functions
No established protein-coding function (As a pseudogene, it does not encode a functional transporter protein)Regulation of gene expression (Some pseudogenes can regulate their parent gene or gene expression through transcriptional interference or RNA mechanisms in general, but no specific function is established for SLC25A3P2)
03
Disease associations
Other (Pseudogenes broadly may have association with gene regulation in cancer and other diseases, but there is no specific case or evidence for SLC25A3P2 itself)
Beyond the preview
Go deeper on Solute carrier family 25 member 3 pseudogene 2 (SLC25A3P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solute carrier family 25 member 3 pseudogene 2 (SLC25A3P2).